tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Seamus Fernandez, 159 are a BUY (79.1%), 42 are a HOLD (20.9%).
Analyst Seamus Fernandez, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 46.65% that have a potential upside of 45.37% achieved within 369 days.
Seamus Fernandez’s has documented 385 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 30-Mar-2026.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for VIE (VIELA BIO) at 1/7/2020. The price target of $45 was fulfilled within 9 days with a profit of $17.12 (61.41%) receiving and performance score of 68.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Dec-2016
$193
$-0.02 (-0.01%)
5 years 11 months 16 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Hold Since 08-May-2019
$203
$9.98 (5.17%)
$178
6 years 1 months 27 days ago
(10-Feb-2020)
5/19 (26.32%)
$4.87 (2.46%)
74
Buy Since 03-Aug-2017
$198
$4.98 (2.58%)
$188
6 years 2 months 15 days ago
(22-Jan-2020)
3/12 (25%)
$7.8 (4.10%)
176
$203
$9.98 (5.17%)
$189
6 years 4 months 18 days ago
(19-Nov-2019)
1/2 (50%)
$19.19 (10.44%)
96
Buy Since 03-Aug-2015
$200
6 years 4 months 18 days ago
(19-Nov-2019)
2/12 (16.67%)
$73.92 (58.63%)
290
Which stock is Seamus Fernandez is most bullish on?
Which stock is Seamus Fernandez is most reserved on?
What Year was the first public recommendation made by Seamus Fernandez?
